Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10964535 | Vaccine | 2014 | 8 Pages |
Abstract
Although IMD is uncommon, the disease severity and associated long-term sequelae result in high health care costs, which should be considered in meningococcal B vaccine funding considerations.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Bing Wang, Hossein Haji Ali Afzali, Helen Marshall,